Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: george eberting who wrote (3480)	12/14/2000 2:11:16 PM
From: rli123	Read Replies (1) \| Respond to of 5582

Speaking of testimonials, did anybody see the one from Mariel Hemingway (I think I've got the name right) on about December 3rd or 4th (a week-and-a-half ago)?? She said something about how she had a cold coming on and used Zicam and snuffed it out. Or something to that effect. I think it was on a news wire. Is there an easy way to do a search for it?? CC: regarding Zicam vs. nic gum --- the margins on Zicam are in the range of 75%, while the margins on gum are much less. Also, there's much more investment necessary to make gum -- you could make Zicam in an FDA-approved bath tub with an FDA-approved canoe paddle. Regardless, both products have major-league potential. I tend to side with you with respect to preferring a "space" that has less competition --- going toe-to-toe with the big guys (with big marketing budgets) is quite a challenge. Let's see how Zicam does this season. rli